Evidence map›Paper›PMID 41520105›Full record

ArticleRadiation oncology (London, England)2026

Postoperative recurrence patterns and anatomy-stratified clinical target volume delineation in pancreatic cancer.

Yunfan Ge, Boyu Leng, Wenheng Jiang, Lei Xu, He Tian, Jinbo Yue

Abstract read
In one paragraph

Article in Radiation oncology (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yunfan Ge *Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Boyu Leng *Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Wenheng JiangDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Lei XuDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China. len.xu@hotmail.com.
He TianDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China. Tianhejn@sina.com.
Jinbo YueDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China. jbyue@sdfmu.edu.cn.

Funding

Collaborative Academic Innovation Project of Shandong Cancer Hospital ZF004National Natural Science Foundation of China 82272753
6 · The paper itself

Abstract

objectivesThis study aims to characterize postoperative recurrence patterns and anatomical distribution in patients with pancreatic cancer within the framework of extrapancreatic neural tract anatomy. Based on the observed recurrence sites, we propose stratified clinical target volume (CTV) delineation recommendations for postoperative adjuvant radiotherapy.

methodsWe retrospectively analysed 352 patients who underwent resection for pancreatic adenocarcinoma and recorded the sites of initial postoperative recurrence. Recurrence foci were reconstructed according to adjacent anatomical structures and mapped onto reference computed tomography images of the pancreatic head and of the body/tail. Spatial distances and distribution relative to major vessels were measured to define vessel-anchored CTV extension ranges for different primary tumour locations. These ranges were compared with the delineation recommendations of RTOG 0848 and the NRG consensus guidelines.

resultsRecurrence occurred in 285 patients (81%), with 187 head tumours and 98 body/tail tumours. Regional failures clustered along a limited number of extrapancreatic plexus pathways. In both head and body/tail tumours, more than four fifths of plexus-related recurrences arose along a pancreatic head plexus II (PLph II)/ superior mesenteric artery (SMA) plexus (PLsma)–celiac axis (CA) plexus (PLce) continuum centred on the axis between the SMA and CA, with a periaortic neurovascular corridor representing the caudal extension of this pathway. We propose a CTV strategy comprising a 0.7 cm margin around the CA, an approximately 1.0 cm margin around the portal vein (PV), common hepatic artery (CHA) and SMA, and an asymmetric periaortic expansion with 1.5 cm anteriorly and to the right, 1.0 cm to the left, and the posterior border confined to the anterior vertebral margin. For pancreatic head tumours, these margins are integrated into a CTV-based “Triangle Volume (TV)” that extends from the PV/CHA–SMA–CA triangle back to the periaortic corridor. For body and tail tumours, the CTV prioritises coverage of the CA–SMA–proximal periaortic neurovascular corridor while avoiding routine inclusion of the distal splenic artery and splenic hilum.

conclusionsVessel-anchored mapping validates the TV framework for pancreatic head tumours and provides quantitative, anatomy-stratified CTV recommendations for pancreatic head and body/tail primaries in the adjuvant setting.

Indexed as

AdenocarcinomaNeoplasm Recurrence, LocalPancreatic NeoplasmsRadiotherapy Planning, Computer-AssistedAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedPrognosisRadiotherapy, AdjuvantRetrospective StudiesTomography, X-Ray ComputedPancreatic cancerPostoperative adjuvant radiotherapyRecurrence patternsSpatial locationTarget volume

Identifiers

PMID41520105
PMCPMC12874955

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.